A recent study has suggested that a polymorphism in the hKCa3 potassium channel may be associated with raised susceptibility to schizophrenia.
1
This is interesting in view of several repeat expansion detection (RED) studies 2 that have reported an excess of large CAG repeats in psychotic probands. [3] [4] [5] [6] [7] Second, the hKCa3 gene is a functional candidate gene because studies of antipsychotic and psychotogenic compounds suggest that glutamatergic systems modulated by SKCa channels may be important in schizophrenia pathogenesis. 1 In the light of the above, we have tested the hypothesis of an association between schizophrenia and the hKCa3 CAG repeat polymorphism using a case control study design. Under the same model of analysis as the earlier study, schizophrenic probands had a higher frequency of alleles with greater than 19 repeats than controls ( 2 = 2.820, P = 0.047, 1-tail). Our data therefore provide modest support for the hypothesis that polymorphism in the hKCa3 gene may contribute to susceptibility to schizophrenia.
The present study was undertaken using 194 unrelated patients meeting DSM-III-R criteria for schizophrenia and 183 controls matched for age and sex. All individuals were Caucasians born in the UK or Eire. Chandy and colleagues 1 obtained the strongest evidence for an association between schizophrenia and repeat size using an allele dichotomization model under which alleles were classified as large (greater than 19 repeats) or small (19 or fewer repeats). In their analysis of 158 controls and 141 schizophrenic patients (all samples were of French/Alsatian ancestry or North American Caucasians), large repeats were more common in schizophrenics compared with controls (Fisher's exact test P = 0.0035). Interestingly, their analysis of the overall allele frequency distributions using the Wilcoxon Rank-Sum test was less significant (P = 0.024). It is not clear why the potentially more powerful analysis of complete allele distributions should have yielded a lesser degree of significance, although one possibility is that there is a threshold below which repeat size is irrelevant and merely contributes noise to the analysis. Whatever the explanation, our data mirror the previous findings. Thus, in our study, when the alleles were dichotomized into Յ 19 and Ͼ19, schizophrenic probands had a higher frequency of alleles with Ͼ19 repeats than did controls ( 2 = 2.820, 1 d.f., P = 0.047, 1-tail). However, a comparison of the allele frequency distributions did not meet conventional levels of significance (ie P Յ 0.05) (Mann-Whitney: U = 67440, W = 134601, P = 0.11 (1-tail) ).
Bearers of at least one allele greater than 19 repeats were more frequent in probands than controls but this also failed to approach conventional levels of statistical significance ( 2 = 1.65, 1 d.f., P = 0.10, 1-tail). We found no association between repeat size and gender in the schizophrenic samples ( 2 = 0.097, 1 d.f., P = 0.76 (2-tail) but we did find that a later age-at-onset was associated with larger allele size (Mann-Whitney: U = 2625.5, W = 6084.5, P = 0.046 (2-tail)) which is contrary to our expectations.
From the analysis above, we conclude that our results are compatible with the hypothesis of Chandy and colleagues, 1 that is, our data provide support for an association between moderately large CAG repeats in the hKCa3 gene and schizophrenia. Although we only found a lesser trend for larger repeats in the patient group under the comparison of the overall allele frequencies, dichotomization of the sample according to the method used in the original study 1 yielded a result that meets conventional criteria of P р 0.05. We would stress that the dichotomization of alleles in this study was not a post hoc manipulation of the data and is justified by the prior hypothesis under investigation here.
Nevertheless, we would continue to suggest that this association be treated cautiously. The statistical evidence from both studies is not conclusive in view of the total number of potential candidate genes and the low prior probability of any given polymorphism being involved in the disease. Furthermore, while the hKCa3 gene is a reasonable candidate gene for schizophrenia as discussed above, the a priori case is not as strong as it might appear at first sight because the size of the repeat is too small to account for the RED data that have suggested an association between large CAG repeats and psychosis. [3] [4] [5] [6] [7] It should, however, also be noted that while the RED studies cannot be taken as supportive of the association between hKCa3 and psychosis, equally, they do not exclude such a possibility, nor does the size of the repeat in the hKCa3 gene alone exclude a pathogenic role since it is comparable to the size of repeat that causes SCA 6. 8 Our finding that a later age-at-onset is associated with a larger repeat length is contrary to expectations of the properties of disease-releated trinucleotide repeats. The original study 1 did not look at repeat length as a function of age-at-onset and therefore although aetiological heterogeneity would allow a plausible explanation of this phenomenon (with earlier age-at-onset cases being caused by factors unrelated to the hKCa3 repeat), further speculation is not warranted while ours remains an isolated finding.
In the light of the above remarks it is clear that while the results reported here and elsewhere 1 are consistent with the hypothesis of Chandy and colleagues, 1 further studies are required to provide definitive evidence for an association. It is therefore worth commenting upon the minimum size of study that is likely to provide useful data. In this study, the estimated odds ratio (OR) for the allelic association is very modest (OR = 1.36) and rather lower than that in the study of Chandy and colleagues (which we estimate to be OR ෂ 2). We estimate that a sample of our size has power between 96% and Ͼ99% (power varies with control allele frequencies which differ in our study and that of Chandy and colleagues) to detect an effect size of OR = 2 at test size (P) р0.05 whereas for the smaller effect size reported here (odds ratio = 1.3-1.4) a sample of our size only has about 66% power even at a relaxed test size of (P) р0.15. It follows therefore that much larger samples will be required to definitively test the hypothesis, and that association studies with sample sizes less than the present study will be of extremely limited value.
A further point is that even if the association reported here and elsewhere 1 is correct, it should not be assumed that the polyglutamine sequence in the hKCa3 channel is directly involved in increased susceptibility to schizophrenia. The possibility remains that the polymorphic repeat in hKCa3 is merely in linkage disequilibrium with the true disease-related polymorphism which lies elsewhere in the gene or indeed a neighbouring gene.
In summary then, we conclude that the data in this study provide limited support for the hypothesis tested here, that is, that modest enlargements of a CAG repeat in the hKCa3 potassium channel are associated with schizophrenia.
Methods

Samples
The case control study was undertaken using 194 unrelated Caucasians meeting DSM-III-R criteria for schizophrenia and 183 controls matched for age and sex. All individuals were Caucasians born in the UK or Eire. The patients included single affected individuals from 129 families containing two or more cases of schizophrenia. The remaining 65 subjects were recruited from local (South Wales) inpatient and day hospital facilities. The patient group consisted of 135 males and 59 females with a mean age of 45 years (s.d. 13). Diagnoses were made using OPCRIT version 3.31 9 using all available data which included a semi-structured interview (SCAN, 10 PSE9 11 ) and case notes. Age-at-onset was defined as age at first psychiatric contact. The controls consisted of 123 males and 60 females with a mean age of 43 years (s.d. 12). The controls were group matched to probands for age, sex and ethnicity from more than 700 blood donors recruited from the local branch of the National Blood Transfusion Service (Wales). Controls were not specifically screened for psychiatric disorder 12 but individuals taking medication are excluded from donating blood. Ethical approval for molecular genetic studies of schizophrenia was obtained from the South Glamorgan Local Research Ethics Committee. After a complete description of the study to the subjects, written informed consent was obtained.
Genotyping
Published primers for the CAG repeat corresponding to the CHLC marker GTC10H06 13 were purchased from Gibco BRL (Paisley, Scotland). Although the primer sequences are not the same as those used by Chandy and colleagues, 1 the STS sequence on which the marker is based corresponds to the polymorphic repeat in hKCa3.
1 Also, we have obtained identical allele sizes in a subset of our sample using the primer pairs published by Chandy and colleagues 1 and also have obtained accurate allele sizing with our primers on cloned repeats of a known size (data not shown). Furthermore, the allele frequencies in this study and that of Chandy and colleagues are almost identical which provides convincing evidence that the amplified repeat is the same.
PCR was carried out using high molecular weight genomic DNA isolated from lymphocytes by phenol/chloroform extraction. Satisfactory amplification of this repeat was not obtained under the conditions routinely suggested by CHLC. Instead, reproducible amplification was achieved using an MJ PTC-100-96 VH thermocycler with heated bonnet (MJ Research, MA, USA) and the following touch-down PCR programme. A denaturation step of 94°C for 5 min was followed by an initial cycle consisting of 1 min of denaturation at 94°C, 2 min of primer-annealing at 65°C and 1 min of optimal DNA-synthesis at 72°C. The primer-annealing temperature was then reduced over the next 12 cycles by 0.5°C per cycle to a final value of 59°C. The touchdown step was followed by 22 cycles consisting of 94°C for 30 s, 58°C for 30 s and 72°C for 1 min.
Reactions were carried out in a volume of 12.5 l comprising 1 × PCR buffer containing 1.5 mM MgCl 2 (Amersham, Slough, UK), 40 ng of DNA, primers at 0.6 M (forward primer 5′ end-labelled with ␥-33 P dATP), dNTPs at 0.08 mM and 0.5 U of Taq polymerase (Amersham). PCR products were separated by denaturing electrophoresis on 6% polyacrylamide gels, detected by overnight autoradiography and sized by comparison with single-stranded M13mp18 control DNA which was sequenced with primer-40 (Amersham) as described elsewhere.
14 Alleles were scored independently by two laboratory staff.
It is possible that differential amplification of small repeats might lead to the misclassification of individuals with very large repeats as homozygotes because of relative amplification failure of the large alleles. To avoid this error, apparent homozygotes were investigated further by subjecting their PCR products to Southern blotting and probing with a labelled CAG repeat oligonucleotide as described. 15 No further alleles were found (data not shown), therefore it is extremely unlikely that this possible error influenced the results.
Statistical analysis
We analysed the data by the methods used in the study that generated the prior hypothesis upon which this investigation was based. 1 Thus the sample was dichotomised at the modal repeat length of 19 repeats and the hypothesis of an association between schizophrenia and larger repeats tested by 2 . The MannWhitney U test was used to compare distributions of allele sizes in patients and controls. Because the aim of the present study was replication of the finding of Chandy and colleagues 1 with a known direction of effect, we used one-tail tests of significance.
Possible association between allele size and age-atonset and gender were explored only under the dichotomization model to minimise multiple testing. The Mann-Whitney U test (2-tailed) was used to examine age-at-onset while a gender effect was examined by chisquare (2-tailed).
Statistical analyses were done on SPSS for Windows version 7. Power calculations were done on nQuery Advisor Release 2 (Dixon Statistical Associates, LA, USA) using a 2 test of the dichotomised allele distributions.
